Delinia is well-capitalized by world-class US and European venture capital firms, Atlas Venture and Sofinnova Partners.
Atlas Venture is a biotech-focused, early-stage venture capital firm that creates and invests in life sciences startup companies in the U.S. Atlas is based in Cambridge, Massachusetts. Since 1993, Atlas has invested in over 150 early stage life sciences companies. For more information, please visit atlasventure.com.
Sofinnova Partners is an independent venture capital firm based in Paris which invests in early stage Life Sciences (Biopharmaceuticals / Biotech, Medical Devices, Industrial Biotechnology) companies. Sofinnova Partners sit on the boards of our portfolio companies, and play an active role from the formation phase alongside entrepreneurs. For more information please visit sofinnova.fr/en